In this episode, Rob and Greg are joined by guest Ted Slafsky, of 340B Report and Wexford Solutions (13:20). Ted shares his thoughts on the ongoing contract pharmacy impasse, updates on legislative developments coming out of D.C., and highlights some of the emerging advocacy groups as the debate over 340B Program reform heats up.   

But first, Greg and Rob discuss upcoming recertification for grantee-covered entities and debate what the end of the COVID-19 Public Health Emergency means for 340B covered entities.